Houlihan Lokey Advises Lightyear Capital

Houlihan Lokey is pleased to announce that Lightyear Capital (Lightyear) has completed a strategic investment in CuraLinc Healthcare (CuraLinc), a leading, innovative provider of employee assistance, student and workforce mental health programs to employers across the U.S. The transaction closed on August 2, 2024.

Lightyear is a New York-based private equity firm that partners with growing companies at the nexus of financial services and technology, healthcare, and business services. For more than 20 years, Lightyear has worked closely with management and leveraged its industry expertise, network of advisors, and operating resources to accelerate growth and build market-leading businesses.

CuraLinc provides transformative mental health care fueled by connectivity—marrying technology and personalized advocacy to support employees, families, and students through programs that have a measurable impact on their health, well-being, and productivity.

Houlihan Lokey served as the exclusive buyside advisor to Lightyear. This transaction underscores the leadership position and continued momentum in both payor services and behavioral healthcare by our dedicated coverage teams.

RELATED: Healthcare